SGCG and neoplasm: Interleukin-4 (IL4), a key cytokine for Th2 differentiation, binds to IL4R, forming the type I IL4 receptor (IL4R-IL2RG) on lymphoid cells and the type II IL4 receptor (IL4R-IL13RA1) on non-lymphoid and tumor cells.